Improved Oral Anticoagulation After a Dietary Vitamin K–Guided Strategy-Reference-Cited by-同舟云学术

Improved Oral Anticoagulation After a Dietary Vitamin K–Guided Strategy

Published:2009-09-22 Issue:12 Volume:120 Page:1115-1122
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

de Assis Michelli C.¹,Rabelo Eneida R.¹,Ávila Christiane W.¹,Polanczyk Carisi Anne¹,Rohde Luis E.¹

Affiliation:

1. From the Cardiovascular Division of Hospital de Clínicas de Porto Alegre, Postgraduation Program in Cardiology and Cardiovascular Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management

2. Managing Oral Anticoagulant Therapy

3. Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation

4. Oral anticoagulants

5. Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Description of self-care behaviours in patients with non-valvular atrial fibrillation on oral anticoagulant therapy: a scoping review;European Journal of Cardiovascular Nursing;2024-01-24

2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

4. Influence of Vitamin K intake on INR and Anticoagulation in outpatients taking Warfarin;Research Journal of Pharmacy and Technology;2022-10-21

5. Real‐life contemporary vitamin K antagonist is still associated with very low time in therapeutic range despite strict international normalized ratio monitoring: Results of big data analysis;Journal of Clinical Pharmacy and Therapeutics;2022-03-29